Purdue unit sued over patent extension for opioid Targin
Healthcare 2022-11-24 11:53 pm By Cindy Cameronne Sydney
Please login to bookmark Close

Australian pharmaceutical company AUPharma has sued the international arm of Purdue, alleging it was wrongly granted patent extensions for several oxycodone products marketed as Targin. 

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au